99 related articles for article (PubMed ID: 10493226)
1. Limitations of established antithrombotic strategies.
Haas S
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S11-8. PubMed ID: 10493226
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
Prandoni P; Simioni P; Pagnan A
Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
[TBL] [Abstract][Full Text] [Related]
3. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
Hirmerová J
Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
[TBL] [Abstract][Full Text] [Related]
4. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.
Motsch J; Walther A; Bock M; Böttiger BW
Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433
[TBL] [Abstract][Full Text] [Related]
5. Clinical limitations of risk assessment models.
Lassen MR; Borris LC; Backs S; Kaltoft-Sørensen M; Coff-Ganes H; Jeppesen E
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S45-51. PubMed ID: 10493230
[TBL] [Abstract][Full Text] [Related]
6. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
7. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
8. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
Kamphuisen PW; Agnelli G
Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of venous thrombosis: role of heparins].
Wahl D; Lepaux DJ; Piquemal R; Frédéric M; Cayrol C; Lecompte T; Thibaut G
Therapie; 1998; 53(6):575-8. PubMed ID: 10070236
[TBL] [Abstract][Full Text] [Related]
10. Evolution of therapies in deep vein thrombosis management.
ten Cate JW
Blood Coagul Fibrinolysis; 1999 Aug; 10 Suppl 2():S5-10. PubMed ID: 10493225
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
12. Heparins and venous thromboembolism: current practice and future directions.
Prandoni P
Thromb Haemost; 2001 Jul; 86(1):488-98. PubMed ID: 11487039
[TBL] [Abstract][Full Text] [Related]
13. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
Colwell C; Mouret P
Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
Nishioka J; Goodin S
J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of venous thromboembolism in internal medicine and neurology].
Malý J; Dulícek P; Penka M; Malý R; Gumulec J
Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
[TBL] [Abstract][Full Text] [Related]
16. [State of the art: low-molecular-weight heparin and beyond].
Cimminiello C; Casali G; Vitali L
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
[TBL] [Abstract][Full Text] [Related]
17. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
18. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery.
Wu EC; Barba CA
Obes Surg; 2000 Feb; 10(1):7-13; discussion 14. PubMed ID: 10715636
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism prophylaxis in medical patients: future perspectives.
Imberti D; Prisco D
Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]